HALO logo
halo search icon
Veracyte, Inc.

US$45.19

Price Change Indicator
3.50 (8.40%)
Veracyte, Inc.
VCYT · NAS

Veracyte, Inc.

Start Trading VCYT for Free

US$45.19

Price Arrow3.50 (8.40%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Balance SheetHALO Earnings MomentumHALO GARPHALO GrowthHALO Momentum+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Veracyte, Inc. Overview

VCYT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About VCYT

icon
icon

Telephone

1.650.243.6300

icon

Address

Suite 300, 6000 Shoreline Court, South San Francisco, CA 94080

Description

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

VCYT Price Chart

Key Stats

Market Cap

US$3.33B

PE

51.10

EV/EBITDA

25.9

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 22.61 - 50.71

Trade Value (12mth)

US$8,795,502.00

1 week

8.34%

1 month

24.41%

YTD

-1.65%

1 year

51%

All time high

86.03

Key Fundamentals

EPS 3 yr Growth

-265.20%

EBITDA Margin

22.20%

Operating Cashflow

$136m

Free Cash Flow Return

10.60%

ROIC

5.20%

Interest Coverage

NaN

Quick Ratio

7.80

Other Data

Shares Outstanding (Fully Diluted)

81m

HALO Sector

Healthcare

Next Company Report Date

01-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VCYT Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
06 May 26

VCYT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.020.320.84locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.020.310.82locklocklock
Growth
 %locklocklocklock-100.4130.8167.6locklocklock
PE
 XlocklocklocklockN/A128.251.1locklocklock
EV/EBITDA
 Xlocklocklocklock117.849.525.9locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Veracyte, Inc. (VCYT:NAS)?
Halo FAQ
The current share price of Veracyte, Inc. (VCYT:NAS) is USD$45.19.
What is the 52-week high share price for Veracyte, Inc. (VCYT:NAS)?
Halo FAQ
The 52-week high share price for Veracyte, Inc. (VCYT:NAS) is USD$50.71.
What is the 52-week low share price for Veracyte, Inc. (VCYT:NAS)?
Halo FAQ
The 52-week low share price for Veracyte, Inc. (VCYT:NAS) is USD$22.61.
What is the dividend yield for Veracyte, Inc. (VCYT:NAS)?
Halo FAQ
Veracyte, Inc. (VCYT:NAS) does not pay a dividend.
What was Veracyte, Inc. (VCYT:NAS) last dividend payment?
Halo FAQ
Veracyte, Inc. (VCYT:NAS) does not pay a dividend.
What is the franking level for Veracyte, Inc. (VCYT:NAS)?
Halo FAQ
Veracyte, Inc. (VCYT:NAS) has a franking level of 0.00%.
In which sector is Veracyte, Inc. (VCYT:NAS) classified?
Halo FAQ
Veracyte, Inc. (VCYT:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Veracyte, Inc. (VCYT:NAS)?
Halo FAQ
The current P/E ratio for Veracyte, Inc. (VCYT:NAS) is 51.10.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial